Evidence map›Paper›PMID 33204088›Full record

ArticleInternational journal of nanomedicine2020

A New Type of MgFe

Hongxia Peng, Menglin Wang, Chuanyue Hu, Jun Guo

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Noninvasive Delivery of Biologicals to the Brain.Focus (American Psychiatric Publishing) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hongxia PengHunan Provincial Key Laboratory of Fine Ceramics and Powder Materials, Hunan University of Humanities, Science and Technology, Lou'di, Hunan, People's Republic of China.
Menglin WangHunan Provincial Key Laboratory of Fine Ceramics and Powder Materials, Hunan University of Humanities, Science and Technology, Lou'di, Hunan, People's Republic of China.
Chuanyue HuHunan Provincial Key Laboratory of Fine Ceramics and Powder Materials, Hunan University of Humanities, Science and Technology, Lou'di, Hunan, People's Republic of China.
Jun GuoHunan Provincial Key Laboratory of Fine Ceramics and Powder Materials, Hunan University of Humanities, Science and Technology, Lou'di, Hunan, People's Republic of China.
Hunan University of Humanities, Science and Technology · CNState Key Laboratory of Powder Metallurgy

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCancer is a major health problem worldwide, and the most extensive treatment can be obtained by using chemotherapy in the clinic. However, due to the low selectivity of cancer cells, chemotherapy drugs produce a series of grievous side effects on normal cells.

methodsIn this research, we developed novel nanocarriers for magnetically targeted near-infrared (NIR) light-electromagnetic wave dual controlled drug delivery based on MgFe

resultsThe results showed that APTES-modified MgFe DISCUSSION: Our findings indicate that multifunctional APTES modified MgFe

Indexed as

LightMagnetic PhenomenaMicrowavesCopperDelayed-Action PreparationsDrug CarriersFerric CompoundsHumansMagnesium CompoundsNanoparticlesNeoplasmsPropylaminesSilanesamino-propyl-triethoxysilaneCoppercupric sulfideDelayed-Action PreparationsDrug CarriersFerric CompoundsMagnesium Compoundsmagnesium ferritePropylaminesSilanesdual controlled releasemagnetic targetingMgFe2O4@CuSNIR light-electromagnetic wave heat conversion property

Identifiers

PMID33204088
PMCPMC7667186
OpenAlexW3101962221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.